Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2176 to 2190 of 8240 results

  1. Neuromodulation for chronic pelvic pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. MRI guided transurethral high intensity ultrasound ablation of the prostate

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Radiofrequency denervation for OA shoulder pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Transbronchial lung cryobiopsy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Vaginal microbiota seeding for neonates

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Mechanical Thrombectomy for PE

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Imbio CT lung texture analysis for identifying interstitial lung disease (MT618) (MIB272)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  10. Dupilumab for treating eosinophilic oesophagitis in children 1 to 11 years [ID6492]

    Awaiting development Reference number: GID-TA11383 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

    Topic prioritisation

    Health technology evaluations
    Topic prioritisation

  12. Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]

    Awaiting development Reference number: GID-TA11494 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Venglustat for treating type 3 Gaucher disease in people aged 12 and over after at least 3 years of enzyme replacement therapy [ID6295]

    Awaiting development Reference number: GID-TA11326 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Durvalumab for adjuvant treatment of hepatocellular carcinoma at high risk of recurrence after curative liver resection or ablation [ID6206]

    Awaiting development Reference number: GID-TA11161 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation